MAVENIR
solutions by stc, the leading enabler of digital transformation in Saudi Arabia and the region, announces an Open RAN agreement with Mavenir, the cloud-native network infrastructure provider building the future of networks, to launch the first commercial Open RAN network in Saudi Arabia. The announcement is a boost to stc’s Group strategic mission to deliver emerging technology to the Kingdom’s mobile customers, supporting the Vision 2030 digital transformation strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226664170/en/
Signing ceremony at Mobile World Congress (MWC) on stc stand in Hall 3. Executive company representatives: Yousef Almarshad, Chief Commercial Officer at solutions by stc & Pardeep Kohli, Chief Executive Office at Mavenir. (Photo: Business Wire)
The service is expected to go-live commercially with its next-generation Open RAN network in 2024, this decision follows a successful initial deployment for multi-layer 4G and 5G NSA Access Network on the Open RAN platform to stc, delivered in partnership with solutions by stc and Mavenir.
The newly launched multi-layered 4G and 5G Radio network will utilize Mavenir’s 4G Remote Radio Unit (RRU) and 5G Massive MIMO (mMIMO) Active Antenna Unit (AAU) technology and leverage the cloud-native Mavenir Webscale Platform (MWP) with fully containerized Centralized Unit (CU) and Distributed Unit (DU) software. The solution will run on x86 commercial-off-the-shelf (COTS) hardware platform that represents best-in-class technology for open interface radio systems. Mavenir and Saudi Arabia-based partner solutions by stc will provide stc with a cloud-native deployment solution that harnesses a full combination of expert professional services plus cutting-edge hardware and software and seamlessly integrated into stc’s radio network.
Yousef Almarshad, Chief Commercial Officer of solutions by stc commented: “Mavenir’s Open RAN technology innovation, together with solutions by stc unrivalled experience in the Saudia Arabia market, provide a strong foundation for this trail-blazing Open RAN deployment, bringing the next-generation performance and breakthrough services to stc’s valued customers across the Kingdom – going beyond data speeds to a more sustainably, securely and cost-effective network powered by Mavenir’s Open RAN.”
BG Kumar, President, Access Networks, Platforms and Digital Enablement at Mavenir, added: “Mavenir is extremely pleased to be awarded with the opportunity to build the first commercial Open RAN deployment in Saudi Arabia in collaboration with solutions by stc. Mavenir is confident that stc’s Open RAN network in Saudi Arabia will act as a catalyst for further accelerating operators’ digital transformation journeys across the Middle East region, ushering in a wave of customer-focused innovation that can fully leverage the unique potential generated by open standards and architecture.”
About stc Group:
stc group is an engine of digital transformation in the region, offering advanced solutions and driving the digitisation process. The group offers landline and fixed infrastructure, mobile and data services, and broadband & cloud computing services. www.stc.com.sa
About solutions by stc:
solutions by stc represents the driving force of digital transformation in the Kingdom of Saudi Arabia and the region, and the number one provider of information technology solutions in Saudi.
solutions aims to empower the public and private sectors by meeting the requirements of the digital age and adopting its latest trends. It also works to provide its customers with a diverse portfolio of services and products to support their daily operations, as the basic communications and information technology services provided by the company are designed to enable management and expansion of business.
solutions by stc started its operations more than 25 years ago and has provided its services to nearly 24,000 clients in 35 cities in Saudi Arabia and the region. The company's experience spans across several key sectors, including banking, healthcare, education, oil and gas, real estate, and telecom. The company has approximately 1,700 employees, including more than 1,000 with certifications in core technology areas. www.solutions.com.sa
About Mavenir:
Mavenir is building the future of networks today with cloud-native, AI-enabled solutions which are green by design, empowering operators to realize the benefits of 5G and achieve intelligent, automated, programmable networks. As the pioneer of Open RAN and a proven industry disruptor, Mavenir’s award-winning solutions are delivering automation and monetization across mobile networks globally, accelerating software network transformation for 300+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. For more information, please visit www.mavenir.com
Meet Mavenir at Mobile World Congress 2024 (Barcelona, Feb 26 – 29 2024)
To explore our latest innovations, MWC show announcements and learn more about how Mavenir is delivering the Future of Networks – Today, visit our team in Hall 2 (Stand 2H60).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226664170/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom